Bui Lecture.pdf

More documents

Recommendations

Info

Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis Brooke Ancrile, Kian-Huat Lim,, and Christopher M. Counter. G&D 2007. Other studies show ras induces IL-6, IL-8, Gro-1. Blocking these cytokines block rasinduced tumor formation.
Corollary to Cancer Immunoediting: Tumorigenesis must induce immune recognition Normal Cells Not recognized Tumorigenesis ? Transformed Cells Well recognized -Are there molecules that are induced by tumorigenesis that mediate immune recognition? What are the signals that control the expression of these molecules? -How likely is it that tumorigenesis induces immune recognition? -What cells recognize nascently transformed tumors?
Page 1 and 2:
Tumor Immunology Jack Bui, MD, PhD
Page 4 and 5:
Tumor immunology = the study of wha
Page 6 and 7: Immune cells function to eliminate
Page 8 and 9: Figure 15.12d The Biology of Cancer
Page 10 and 11: The birth of tumor immunosurveillan
Page 12: Paradigm shift : Cancers are opport
Page 15: Shankaran et al., Nature 2001 Mice
Page 18 and 19: The presence of tumor specific T ce
Page 20 and 21: Evidence for tumor immunosurveillan
Page 22 and 23: Shown is survival in ovarian cancer
Page 24: Endogenous T Cell Responses to Anti
Page 28 and 29: Goals 1. Present evidence that the
Page 30 and 31: Shankaran et al., Nature 2001 WT tu
Page 32 and 33: Cancer immunoediting: regressor tum
Page 35 and 36: Evidence for equilibrium • Human
Page 37 and 38: Melanoma complicating treatment wit
Page 39 and 40: Implications of equilibrium state
Page 41 and 42: Inflammation and Cancer: “Cancers
Page 43 and 44: Evidence for inflammation induced c
Page 45 and 46: Deletion of the NF-kB activator IKK
Page 47 and 48: Goals 1. Present evidence that the
Page 49 and 50: Evidence for Cancer Immunoediting:
Page 51 and 52: Normal cell Not recognized Induced-
Page 53 and 54: Gasser et al., DNA damage induces N
Page 55: Evidence for p53’s role in activa
Page 59 and 60: Passenger mutations leading to neo-
Page 61 and 62: Oncogene-driven models of cancer ca
Page 63 and 64: Goals for this hour 1. Present evid
Page 65 and 66: What cells/molecules promote vs inh
Page 67 and 68: Immune therapy of melanoma • IL-2
Page 69: Peripheral blood mononuclear cells
Page 74 and 75: An example of immunotherapy
Page 76 and 77: The presence of tumor specific T ce
Page 78: Can we remove immune suppression?
Page 81 and 82: Cancer immunoediting describes the
Page 83: Some major unanswered questions •
show all

Bui Lecture.pdf

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?